These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3842314)

  • 1. Cell surface antigens of melanocytes and melanoma.
    Albino AP; Houghton AN
    Cancer Surv; 1985; 4(1):185-211. PubMed ID: 3842314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
    Old LJ
    Cancer Res; 1981 Feb; 41(2):361-75. PubMed ID: 7004632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunology: the search for specificity.
    Old LJ
    Natl Cancer Inst Monogr; 1982; 60():193-209. PubMed ID: 6181408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.
    Lehmann JM; Holzmann B; Breitbart EW; Schmiegelow P; Riethmüller G; Johnson JP
    Cancer Res; 1987 Feb; 47(3):841-5. PubMed ID: 3542195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentiation antigens of melanoma and melanocytes by mouse and human monoclonal antibodies.
    Houghton AN
    Transplant Proc; 1984 Apr; 16(2):351-4. PubMed ID: 6144202
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation antigens of melanoma and melanocytes.
    Houghton AN; Cordon-Cardo C; Eisinger M
    Int Rev Exp Pathol; 1986; 28():217-48. PubMed ID: 3516910
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
    Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
    Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serological analysis of human cancer. Identification of differentiation antigens on melanoma and melanocytes.
    Houghton AN
    Prog Clin Biol Res; 1983; 119():199-205. PubMed ID: 6867027
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells.
    Bernsen MR; Diepstra JH; van Mil P; Punt CJ; Figdor CG; van Muijen GN; Adema GJ; Ruiter DJ
    J Pathol; 2004 Jan; 202(1):70-9. PubMed ID: 14694523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responses.
    Parmiani G; Anichini A; Castelli C
    Melanoma Res; 1997 Aug; 7 Suppl 2():S95-8. PubMed ID: 9578423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
    Houghton AN; Eisinger M; Albino AP; Cairncross JG; Old LJ
    J Exp Med; 1982 Dec; 156(6):1755-66. PubMed ID: 7175440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational development of tumour antigen-specific immunization in melanoma.
    Gajewski TF; Fallarino F
    Ther Immunol; 1995 Aug; 2(4):211-25. PubMed ID: 9358613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro differentiation of human melanoma cells analyzed with monoclonal antibodies.
    Ziegler-Heitbrock HW; Munker R; Johnson J; Petersmann I; Schmoeckel C; Riethmüller G
    Cancer Res; 1985 Mar; 45(3):1344-50. PubMed ID: 3971378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological analysis of melanoma patients receiving autologous melanoma cell vaccines].
    Watanabe T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):261-72. PubMed ID: 6881976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.
    Holzmann B; Johnson JP; Kaudewitz P; Riethmüller G
    J Exp Med; 1985 Feb; 161(2):366-77. PubMed ID: 3973533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro.
    Bakker AB; Marland G; de Boer AJ; Huijbens RJ; Danen EH; Adema GJ; Figdor CG
    Cancer Res; 1995 Nov; 55(22):5330-4. PubMed ID: 7585596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.